Generation Bio Names Phillip Samayoa, Ph.D. Chief Strategy Officer

September 20, 2022

https://www.globenewswire.com/news-release/2022/09/20/2519098/0/en/Generation-Bio-Names-Phillip-Samayoa-Ph-D-Chief-Strategy-Officer.html

CAMBRIDGE, Mass., Sept. 20, 2022 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq:GBIO), a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced the promotion of Phillip Samayoa, Ph.D., to chief strategy officer. Dr. Samayoa has led strategy, corporate and portfolio development at Generation Bio since he joined the company in 2017, most recently serving as senior vice president.

Read more at globenewswire.com

Related news for (GBIO)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.